Navigation Links
Internal Groups are Valuable Sources for Pharmaceutical Competitive Intelligence Function

CHAPEL HILL, N.C., Sept. 13, 2011 /PRNewswire/ -- Pharmaceutical Competitive Intelligence functions look to internal colleagues and departments to unearth critical insights. Internal groups most often receiving the highest value ratings as information sources are Medical Affairs and Medical Science Liaisons.

More than 80 percent of companies currently reach out to Medical Affairs for valuable competitive intelligence. However, nearly one-third of companies do not tap their Medical Science Liaisons for information, according to "Best Practices in Competitive Intelligence: Policies & Guidelines that Reduce Corporate Risks," a primary research study conducted by Best Practices, LLC.

Download a complimentary white paper at that includes selected best practices drawn from extensive primary research with competitive intelligence leaders from 22 different biopharmaceutical companies.

Key insights include:

  • Benchmarked companies use an array of external sources to collect competitive intelligence. Medical congresses are the most used external CI source, and clinical trial investigators the highest rated. Third-party CI vendors rank second in both use and value.
  • The primary source that vendors go to is Key Opinion Leaders. Other top targets are medical congresses and competitor companies.

The full 52-page report contains more than 120 benchmark metrics and 16 executive narratives, providing executives with benchmarks of world-class companies for optimizing CI operations and working with the Legal department to develop policies as well as insights into the best practices for collection, use and sources of primary data - including employment of third party vendors for primary data collection.

For more information on this study and other recent primary research studies, contact us at 919.403.0251 or at  

BEST PRACTICES, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for more than 17 years; our clients include 48 out of the top 50 pharmaceutical companies.

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Building Support for a New Product Through Effective Internal Disease State Communication
2. Pharmaceutical Internal Communications Function Morphs to Address Corporate Priorities
3. Internal Fixation Systems, Inc. Announces Form S-1 Declared Effective by SEC and Anticipated Quotation for Trading on OTCQB
4. Maximizing the Potential of Internal and External Communications Groups
5. Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan
6. SyncMedical Receives ANVISA Regulatory Approval to Offer Spine and Internal Medicine Products in Brazil
7. Toriseva Law and Karon & Dalimonte LLP: Archives of Internal Medicine Article Faults Manufacturers of IVC Filters
8. Corporate Affairs Role in Internal and External Relationships Key to Organizational Success
9. International Medical News Group Relaunches Internal Medicine News Digital Network and Hospitalist News Digital Network
10. Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine
11. Using Internal Communications to Help Build a Credible External Message Regarding New Pharmaceutical Products
Post Your Comments:
(Date:11/26/2015)... , Países Bajos, November 26, 2015 ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... la inmunoterapia con la terapia fotodinámica de Bremachlorin para ... Un nuevo enfoque combina la inmunoterapia con la terapia ... Clinical Cancer Research . --> ...
(Date:11/26/2015)... , Nederland, November 26, 2015 ... Een nieuwe aanpak combineert immunotherapie met ... kanker. ) ...      (Photo: ) ... Leids Universitair Medisch Centrum (LUMC) ...
(Date:11/26/2015)... 3D bioprinting market is expected to reach ... by Grand View Research Inc. Rising prevalence of chronic diseases ... is expected to boost the market growth, as 3D bioprinting ... --> 3D bioprinting market is expected to reach ... by Grand View Research Inc. Rising prevalence of chronic diseases ...
Breaking Medicine Technology:
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... According ... at the recent 2015 American Dental Association meeting in Washington D.C. revolved around the ... protect a patient’s overall health. The talk stressed the link between periodontal disease (more ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has released ... Surviving Mesothelioma has just posted the findings on the website. Click here to ... cases of 136 mesothelioma patients who were treated with chemotherapy followed by EPP surgery. ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with ... digital component is distributed nationally, through a vast social media strategy and across ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for ... of Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... CBD ... Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography ... CAAHEP accredited colleges, as only one of twelve colleges and universities in the state ...
Breaking Medicine News(10 mins):